110 Biggest Movers From Friday
Gainers
ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend to shareholders in form of common shares of Industrial Human Capital.
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 807 companies reached new 52-week lows.
Roivant Subsidiary VantAI Announces Multi-Year Protein Degrader Discovery Collaboration With Janssen
VantAI, an AI-first induced-proximity company, today announced it has entered into a multi-year collaboration agreement with Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson
Roivant’ Dermavant Showcases New Long-Term Durability, Tolerability Data For Plaque Psoriasis Candidate
Roivant Sciences Ltd's (NASDAQ: ROIV) subsidiary Dermavant Sciences announced results from Phase 3 PSOARING 3 long-term extension study of tapinarof cream 1% for plaque psoriasis in adults.
Roivant Sciences’s Dermavant Showcases New Long-Term Durability And Tolerability Data From Phase 3 Psoaring 3 Trial Of Tapinarof Cream For Adults With Plaque Psoriasis At The 2022 AAD Annual Meeting
Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, today announced Phase 3 PSOARING 3 long-term extension study
Sanford Burnham Prebys And Roivant Social Ventures Announce Groundbreaking Partnership To Increase Diversity & Inclusion In Biopharma
Roivant Social Ventures, a nonprofit philanthropic social impact organization launched by Roivant Sciences, today announced a major collaboration with Sanford Burnham Prebys, San Diego’s prestigious medical
Roivant Sciences Q3 Sales $24.34M Beat $9.87M Estimate
Roivant Sciences (NASDAQ:ROIV) reported quarterly sales of $24.34 million which beat the analyst consensus estimate of $9.87 million by 146.62 percent.